Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation.
Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA. Steenbergen P, et al. Among authors: van den bergh l, van der heide ua, van der voort van zyp jr. Radiother Oncol. 2015 May;115(2):186-90. doi: 10.1016/j.radonc.2015.04.012. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935742 Free article.
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial.
Monninkhof EM, van Loon JWL, van Vulpen M, Kerkmeijer LGW, Pos FJ, Haustermans K, van den Bergh L, Isebaert S, McColl GM, Smeenk RJ, Noteboom J, Walraven I, Peeters PHM, van der Heide UA. Monninkhof EM, et al. Among authors: van den bergh l. Radiother Oncol. 2018 Apr;127(1):74-80. doi: 10.1016/j.radonc.2017.12.022. Epub 2018 Jan 11. Radiother Oncol. 2018. PMID: 29336835 Free article. Clinical Trial.
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.
Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, Kunze-Busch M, de Boer JCJ, van der Voort van Zijp J, van Vulpen M, Draulans C, van den Bergh L, Isebaert S, van der Heide UA. Kerkmeijer LGW, et al. Among authors: van den bergh l. J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20. J Clin Oncol. 2021. PMID: 33471548 Clinical Trial.
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Budiharto T, Joniau S, Lerut E, Van den Bergh L, Mottaghy F, Deroose CM, Oyen R, Ameye F, Bogaerts K, Haustermans K, Van Poppel H. Budiharto T, et al. Among authors: van den bergh l, van poppel h. Eur Urol. 2011 Jul;60(1):125-30. doi: 10.1016/j.eururo.2011.01.015. Epub 2011 Jan 18. Eur Urol. 2011. PMID: 21292388
Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L, Koole M, Isebaert S, Joniau S, Deroose CM, Oyen R, Lerut E, Budiharto T, Mottaghy F, Bormans G, Van Poppel H, Haustermans K. Van den Bergh L, et al. Among authors: van poppel h. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1486-92. doi: 10.1016/j.ijrobp.2011.10.046. Epub 2012 Jan 26. Int J Radiat Oncol Biol Phys. 2012. PMID: 22284686
Mapping of pelvic lymph node metastases in prostate cancer.
Joniau S, Van den Bergh L, Lerut E, Deroose CM, Haustermans K, Oyen R, Budiharto T, Ameye F, Bogaerts K, Van Poppel H. Joniau S, et al. Among authors: van den bergh l, van poppel h. Eur Urol. 2013 Mar;63(3):450-8. doi: 10.1016/j.eururo.2012.06.057. Epub 2012 Jul 6. Eur Urol. 2013. PMID: 22795517
41 results